Effect of aminoguanidine on plasma nitric oxide by-products and blood flow during chronic peritoneal sepsis

Shock

Volumn 9, Issue 4, 1998, Pages 289-295

  Alden, Kris J ^a   Motew, Stephen J ^a   Sharma, Avadhesh C ^a   Ferguson, James L ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; MALE; PATHOPHYSIOLOGY; PERITONEAL CAVITY; PHYSIOLOGY; RAT; REFERENCE VALUE; SEPSIS; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; ENZYME INHIBITORS; GUANIDINES; HEART RATE; HEMODYNAMIC PROCESSES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SPECIFICITY; PERITONEAL CAVITY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REGIONAL BLOOD FLOW; SEPSIS; STROKE VOLUME; VASCULAR RESISTANCE;

EID: 0032044129     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199804000-00009     Document Type: Article

References (46)

1. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457-469, 1991.
2. Lang CH, Bagby GJ, Ferguson JL, Spitzer J: Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 246:R331-R337, 1984.
3. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227-242, 1990.
4. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by L-arginine pathway. Am J Physiol 259:H1038-H1043, 1990.
5. Li S, Fan SX, McKenna TM: Role of nitric oxide in sepsis-induced hyporeactivity in isolated rat lungs. Shock 5:122-129, 1996.
6. Michel T, Li GK, Busconi L: Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 90: 6252-6256, 1993.
7. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH: Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-624, 1991.
8. Cho HJ, Xie Q, Calaycay J, et al: Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176:599-604, 1992.
9. Xie Q, Nathan C: The high-output nitric oxide pathway: Role and regulation. J Leukoc Biol 56:576-582, 1994.
10. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
11. Nussler AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 54:171-178, 1993.
12. Kilbourn RG, Griffith OW: Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84:827-831, 1992.
13. Rees DD, Palmer RM, Schulz R, Hodoson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746-752, 1990.
14. Hock CE, Yin K, Yue G, Wong PY: Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am J Physiol 272: H843-H850, 1997.
15. Corbett JA, McDaniel ML: The use of aminoguanidine, a selective iNOS inhibitor, to evaluate the role of nitric oxide in the development of autoimmune diabetes. Methods 1:21-30, 1996.
16. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR: Aminoguanidine attenuated the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114:1666-1672, 1995.
17. Booke M, Hinder F, Traber LD, McGuire R, Traber DL: S-Ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep. Shock 4:274-281, 1995.
18. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies. Shock 5:116-121, 1996.
19. Vromen A, Arkovitz MS, Zingarelli B, Salzman AL, Garcia VF, Szabo C: Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 6:248-253, 1996.
20. Booke M, Hinder F, McGuire R, Traber LD, Traber DL: Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: Effects on regional blood flow. Shock 5:362-370, 1996.
21. Calver A, Collier J, Vallance P: Nitric oxide and cardiovascular control. Exp Physiol 78:303-326, 1993.
22. Balligand JL, Ungureanu D, Kelly RA, et al: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91:2314-2319, 1993.
23. Wehnmalm A, Benthin G, Petersson AS: Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106:507-508, 1992.
24. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
25. Green LC, Ruiz de Luzuriaga K, Wagner DA, et al: Nitrate biosynthesis in man. Proc Natl Acad Sci USA 78:7764-7768, 1981.
26. Sharma AC, Bosmann HB, Motew SJ, et al: Steroid hormone alterations following induction of chronic intraperitoneal sepsis in male rats. Shock 6:150-154, 1996.
27. Law WR, Ferguson JL: Naloxone alters organ perfusion during endotoxin shock in conscious rats. Am J Physiol 255:H1106-H1113, 1988.
28. Tracey WR, Tse J, Carter G: Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluations of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 272:1011-1015, 1995.
29. Sharma AC, Motew SJ, Farias S, et al: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29:1469-1477, 1997.
30. Motew SJ, Mourelatos MG, Miller JAN, Ferguson JL, Law WR: Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats. Shock 7:439-446, 1997.
31. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen levels in patients after trauma and during sepsis. Ann Surg 214:621-626, 1991.
32. Gomes-Jimenez J, Salgado A, Mourelle M, et al: L-Arginine:nitric oxide production in various forms of circulatory shock. Crit Care Med 23:253-258, 1995.
33. Endo S, Inada J, Nakae H, et al: Nitrite/nitrate oxide (NOX) and cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 91:347-356, 1996.
34. Szabo C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 3:2-32, 1995.
35. Hinder F, Booke M, Traber LD, et al: Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit Care Med 24:131-136, 1996.
36. Gardiner SM, Kemp PA, March JE, Bennett T: Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotpxaemia in conscious rats. Br J Pharmacol 118:1822-1828, 1996.
37. Hutcheson IR, Whittle BJR, Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101:815-820, 1990.
38. Laszlo F, Whittle BJR, Moncada S: Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rate intestine by nitric oxide synthase inhibitors. Br J Pharmacol 111:1309-1315, 1994.
39. Cobb JP, Natanson C, Hoffman WD, et al: Nw-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175-1182, 1992.
40. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57, 1992.
41. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM: Inhibition of nitric oxide synthase is detrimental during endotoxemia. Arch Surg 129:142-148, 1994.
42. Corbett JA, Tilton RG, Chang K, et al: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556, 1992.
43. Misko TP, Moore WM, Kasten TP, et al: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119-125, 1993.
44. Hasan K, Heesen BJ, Corbett JA, et al: Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249:101-106, 1993.
45. Meguid RA, Wang P, Chaudry IH: Does endothelin or nitric oxide play any major role in producing hyperdynamic circulation during sepsis? Shock 7(Suppl 2):65, 1997 (abstract).
46. Ohiru T, Yamauchi K, Sekizawa K, et al: Histamine N-methyl-transferase controls the contractile response of guinea pig trachea to histamine. J Pharmacol Exp Ther 261:1268-1272, 1992.